Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Amazon Great Indian Festival 2020 - Electronics

| More

Maintain BUY on Infosys - Positive trends - HDFC Securities

Posted On: 2020-10-15 04:04:36

Mr. Apurva Prasad & Mr. Amit Chandra, Institutional Research Analyst, HDFC Securities

We maintain BUY on Infosys (INFY), following a strong 2Q print across revenue, operations and deal wins translating into growth leadership in FY21. Increase in revenue guidance to 2-3% CC for FY21 and margin guidance increase to 23-24% reflect 2Q outperformance and growth visibility for 2H. Growth visibility is predicated on (1) strongest-ever deal wins with large deal TCV at USD 3,145mn comprising USD 2,705mn in new wins (including Vanguard deal), (2) strong commentary on BFSI vertical (five large deal wins ex-Vanguard), Life-science & Hi-tech verticals and recovery in Retail & CPG vertical (three large deals), (3) better supply-side indicators of a wage increase, local hiring program (margin implications), and (4) traction in digital (47.3% of revenue and 25.4% YoY CC), supported by industry tailwinds of cloud migration/DX projects and vendor consolidation. Our target price of Rs 1,230 is based on 23x Sep-22E EPS (15% discount to TCS) with EPS CAGR at 14% over FY20-23E.

2QFY21 highlights: (1) Revenue came at a eight-quarter high growth of 4% QoQ CC (2.2% YoY CC). (2) EBIT margin was at 18-quarter high of 25.3%, +268bps QoQ supported by pricing, offshore-mix, higher utilisation, lower SG&A and cross-currency offset by INR appreciation. (3) Wage increase effective 4QFY21 and resumption in variable payout and promotion cycle. (4) Local hiring plans of 12,000 over the next two years planned and current localisation at 63% in the US, hiring in Canada/Mexico to offset H-1B regulatory hurdles.

Outlook: INFY's growth leadership and scale, large deal momentum and improving capabilities in Salesforce, ServiceNow, Adobe are key positives. We have factored in USD revenue growth of 5.1%, 11.6%, 10.3% for FY21/22/23E with 3Q/4QFY21 at 3.5/2.5% QoQ. EBIT margin factored in at 24.4/23.0% for 3Q/4Q and 22.8/23.3% for FY22/23E. Valuations are at 22.7/19.9x (~15% discount to TCS) with FY20-23E EPS CAGR at 14%.

Shares of INFOSYS LTD. was last trading in BSE at Rs.1108 as compared to the previous close of Rs. 1136.1. The total number of shares traded during the day was 2663595 in over 41182 trades.

The stock hit an intraday high of Rs. 1185 and intraday low of 1093. The net turnover during the day was Rs. 3032792678.

Source: Equity Bulls

Click here to send ur comments or to

Amazon Great Indian Festival 2020 - Mobiles

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

ICICI Lombard General Insurance - Q2FY21 Result - Angel Broking

Upgrade to BUY on Subros - Margin at multi-quarter high - HDFC Securities

Nestle India Ltd - Q3CY20 Result Update - YES Securities

ICICI Lombard General Insurance - Q2FY21 Result Update - YES Securities

Engineering & Capital Goods - India - In dire stratis - ICICI Securities

Kewal Kiran Clothing - Cost-cutting measures arrest EBITDA fall - ICICI Securities

Aditya Birla Fashion and Retail - Strategic tie-up with Flipkart - ICICI Securities

Tech Mahindra - Can margins surprise further? - ICICI Securities

Nestle India - Capex announcement (Rs26bn over CY20-23) is the highlight - ICICI Securities

ICICI Lombard General Insurance Company - Strong franchise should benefit from cycle recovery - ICICI Securities

YES Bank - Turnaround progressing well; asset quality pangs merely deferred - ICICI Securities

Mphasis - Deal win momentum continued to be impressive - ICICI Securities

ACS sheet industry - Industry tailwinds to sustain - ICICI Securities

Gokaldas Exports - Q2FY21 Company Update - ICICI Securities

Polycab India - Q2FY21 Result Update - ICICI Securities

Cera Sanitaryware - Initiating Coverage - A Quality Play in Building Materials Space - Reliance Securities

Nestle India - 3QCY20 results - First Cut - YES SECURITIES

Crude Oil - Oct 23, 2020 - Reliance Securities

Maintain BUY on Ambuja Cements - Stellar show yet again; dividend bonanza announced - HDFC Securities

ADD on Bajaj Auto - Margin beat - HDFC Securities

Maintain REDUCE on Asian Paints - Standing tall - HDFC Securities

SBI cards - Q2FY21 - Angel Broking

Biocon - Q2FY21 - Angel Broking

Mphasis - Q2FY21 numbers - Angel Broking

L&T Finance Holdings - Q2FY21 - Angel Broking

HDFC AMC - Q2FY21 - Angel Broking

Bajaj Finserv (Not rated) - Q2 FY21 Conference Call Takeaways - YES Securities

Syngene International - Q2FY21 conference call takeaways - YES Securities

SBI Cards Q2FY21 Call Highlights - YES Securities

Sterlite Technologies (Q2FY21) - Conference call takeaways - YES Securities

Asian Paints Ltd - Q2FY21 Result Update - YES Securities

HDFC AMC - Q2FY21 Result Update - YES Securities

Alembic Pharma - Solid delivery continues; Top pick BUY TP Rs 1,180 - YES Securities

Sterlite Technologies - Q2FY21 First Cut - ICICI Securities

Tata Metaliks - Q2FY21 Company Update - ICICI Securities

Bajaj Auto - Q2FY21 First Cut - ICICI Securities

Bajaj Finserv - Q2FY21 Result Update - ICICI Securities

Asian Paints - Q2FY21 First Cut - ICICI Securities

Bharti Infratel - Q2FY21 - Angel Broking

Asian Paints - Q2FY21 - Angel Broking

Bajaj Auto - Q2FY21 numbers - Angel Broking

Maintain ADD on Bajaj Finance - Prudent provisioning hits profits - HDFC Securities

FDA warning letter to Aurobindo Pharma - Angel Broking

Chennai Petroleum - Q2FY221 Results - Angel Broking

Maintain ADD on Colgate Palmolive - Healthy domestic recovery; robust margin show - HDFC Securities

Maintain BUY on UltraTech Cement - Well-rounded performance - HDFC Securities

DB Corp - Q2FY21 Result Update - ICICI Securities

Bajaj Finance - Q2FY21 Result Update - ICICI Securities

Colgate-Palmolive (India) - Q2FY21 Result Update - ICICI Securities

UltraTech Cement - Q2FY21 Result Update - ICICI Securities

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019